S1PR4 receptor agonists (Scripps Research Institute/Harvard Medical School)

N/A

Report date: 2025/03/20 20:00:06
NME

Base Information

Drug NameS1PR4 receptor agonists (Scripps Research Institute/Harvard Medical School)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSphingosine 1-phosphate receptor 4 agonists
TargetsSphingosine 1-phosphate receptor 4
Therapy Area/IndicationsMultiple Sclerosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesThe Scripps Research Institute Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesHarvard Medical SchoolThe Scripps Research Institute Inc
Active IndicationsN/A
Inactive IndicationsMultiple Sclerosis

Other Information

ATC CodeN/A
Related LinksN/A